{"database": "lobbying", "table": "lobbying_activities", "rows": [[1514190, "781e764a-b932-42f4-8fc2-9f7ff74799da", "1T", "MEHLMAN CONSULTING, INC.", 284950, "AMERICAN CLINICAL LABORATORY ASSOCIATION", 2014, "first_quarter", "MMM", "Legislative proposals and policies impacting Medicare reimbursement for clinical lab services, including co-insurance, copayments, competitive bidding, and fee schedule reform and reimbursement.\nProposals concerning the Stark Law's in-office ancillary services exception. (H.R. 2914). \nSee next page for continuation.S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013.\n\nH.R. 2810, SGR Repeal and Medicare Beneficiary Access Act of 2013.\n\nPathway for SGR Reform Act of 2013.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office", 80000, null, 0, 1, "2014-04-11T13:58:37.627000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1514190"], "units": {}, "query_ms": 43.70780900353566, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}